Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma
PHASE2
Safety study of Depigoid vaccine Dermatophagoides pteronyssinus or 50% Derm...
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
PHASE1
The purpose of this pilot study is to evaluate allergen-induced nasal airwa...
Status
Terminated
Location
UNC Center for Environmental Medicine, Asthma and Lung Biology